No Meaningful Drug-Drug Interactions Are Associated with the Coadministration of ACC007, Lamivudine, and Tenofovir Disoproxil Fumarate
暂无分享,去创建一个
Wen Zhang | Xiangmei Zhao | Zhu Tian | Baoshun Li | Xiaohua Hao | Yan Xiao | Lihua Li | Dong Zhao | Jun Ni | Lu Wu
[1] O. Kirk,et al. Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021 , 2022, HIV medicine.
[2] Taisheng Li. Chinese Guidelines for the Diagnosis and Treatment of HIV/AIDS (2021 Edition) , 2022, Infectious Diseases & Immunity.
[3] Eunwoo Kim,et al. Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects , 2021, Translational and clinical pharmacology.
[4] Yong-tang Zheng,et al. The New NNRTI ACC007 Combined with Lamivudine and Tenofovir Disoproxil Fumarate Show Synergy Anti-HIV Activity In Vitro. , 2020, Current HIV research.
[5] W. Kraft,et al. No Meaningful Drug Interactions with Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate Coadministration , 2019, Antiviral therapy.
[6] Murali M. Yallapu,et al. Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment , 2019, Expert opinion on drug metabolism & toxicology.
[7] C. Fichtenbaum,et al. Emerging reverse transcriptase inhibitors for HIV-1 infection , 2018, Expert opinion on emerging drugs.
[8] T. Cihlar,et al. Current status and prospects of HIV treatment. , 2016, Current opinion in virology.
[9] Joo-Youn Cho,et al. Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects , 2014, Drug design, development and therapy.
[10] Jason J Schafer,et al. Rilpivirine, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Management of HIV-1 Infection: A Systematic Review , 2012, Antiviral therapy.
[11] Graham Patrick. Drug Metabolism , 2007, Definitions.
[12] J. Gallant. The Ideal Nucleoside/Nucleotide Backbone , 2004, Journal of acquired immune deficiency syndromes.
[13] G. E. Pakes,et al. Clinical Pharmacokinetics of Lamivudine , 1999, Clinical pharmacokinetics.